levdobutamine 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
13 61661-06-1

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • levdobutamine
  • levdobutamine lactobionate
  • LY206243
Levdobutamine, an investigational drug, is a beta-adrenoceptor agonist selective for the beta1-subtype. It is the cardiotonic agent.
  • Molecular weight: 301.39
  • Formula: C18H23NO3
  • CLOGP: 2.43
  • LIPINSKI: 0
  • HAC: 4
  • HDO: 4
  • TPSA: 72.72
  • ALOGS: -4.34
  • ROTB: 7

Drug dosage:

None

ADMET properties:

None

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

None

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 9.98 acidic
pKa2 10.59 acidic
pKa3 13.49 acidic
pKa4 9.03 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])		Mechanism
action		Bioact sourceMoA source
Beta-1 adrenergic receptor GPCR AGONIST DRUGBANK CHEMBL

External reference:

IDSource
0PE6UXH3WG UNII
D04708 KEGG_DRUG
129388-07-4 SECONDARY_CAS_RN
C5237977 UMLSCUI
CHEMBL1367478 ChEMBL_ID
688441 PUBCHEM_CID
CHEMBL2106421 ChEMBL_ID
6820 INN_ID

Pharmaceutical products:

None